Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the “Company”), a leader in digital transformation solutions including managed services, cloud enablement, and data analytics for the healthcare and ...
KUALA LUMPUR, MY / ACCESS Newswire / February 6, 2026 / Agape ATP Corporation (NASDAQ:ATPC) ("ATPC" or "the Company") announced that it intends to implement a 1-for-50 reverse stock split of its ...
Stocktwits on MSN
Why did Healthcare Triangle stock plummet 20% today?
The consolidation of shares was approved at a special stockholder meeting on February 2. ・The move is part of a broader ...
SELANGOR, Malaysia, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Founder Group Limited (“FGL” or the “Company”) today announced that the authorised, issued, and outstanding shares of the Company will be combined ...
Investing.com -- Utime Limited (NASDAQ:WTO) stock plunged 29.6% in premarket trading Friday after the mobile device maker announced a 5-for-1 share consolidation set to take effect on February 17, ...
UTime Limited (Nasdaq: WTO) today announced that its share consolidation (“Share Consolidation”) involving the consolidation of every five (5) Class A ordinary shares, with a par value of US$0.10 per ...
Herzfeld Credit Income Fund, Inc. (NASDAQ: HERZ) (the “Fund”) confirms today that its Board of Directors has approved implementation of a reverse stock split (the “Reverse Split”) of the Fund’s common ...
Rallybio Corporation (Nasdaq: RLYB) will effect a one-for-eight reverse stock split of its issued and outstanding common stock. Stockholders of Rallybio approved an amendment to Rallybio's Amended and ...
MINNEAPOLIS, MN / ACCESS Newswire / January 30, 2026 / Lendway, Inc. (the "Company") today announced that it will change its corporate name to Bloomia Holdings, Inc. The name change ...
IRVINE, CA / ACCESS Newswire / January 15, 2026 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno Medical" or the ...
ESTERO, FL / ACCESS Newswire / January 14, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the ...
Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), announced today that, on January 28, 2026, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results